The 2017 Off-Label Regulatory Compliance Congress covers topics such as:
- How the 21st Century Cures Act will transform the way that information is disseminated across the industry
- Firsthand accounts from the FDAs Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products public hearing
- Ways to coordinate the availability of science and real-world data with the speed of the regulatory landscape
- A clear definition of scientific communication exchange without fear of persecution
- Case studies to identify how industry leaders develop compliant promotional practices
The 2017 Off-Label Regulatory Compliance Congress brings together attendees from pharmaceutical, medical device and biotechnology companies with responsibilities in
- Legal Affairs/Compliance
- Regulatory Affairs
- Marketing/Advertising and Promotion
- Medical Affairs/MSL
- Clinical/Promotional Review
- Sales
- Medical Information
- Brand Management
- Medical Communication
- Medical Education
- Commercial/Scientific Legal Affairs
- Product Training
- Quality Assurance
Others:
- Compliance Service Providers
- Regulatory Affairs Service Providers/Consultants
- Off-Label Service Providers
- Promotional Review Vendors
- Marketing/Advertising Agencies
- Law Firms